SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

10 Aug 2022 Evaluate
The sales declined to Rs. 19809.00 millions for the June 2022 quarter as compared to Rs. 21234.00 millions during the corresponding quarter last year.Net profit declined -17.10% to Rs. 3315.00 millions from Rs. 3999.00 millions.The Operating Profit of the company witnessed a decrease to 5960.00 millions from 6473.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 19809.00 21234.00 -6.71 19809.00 21234.00 -6.71 79819.00 77800.00 2.60
Other Income 517.00 297.00 74.07 517.00 297.00 74.07 1787.00 893.00 100.11
PBIDT 5960.00 6473.00 -7.93 5960.00 6473.00 -7.93 20968.00 23980.00 -12.56
Interest 406.00 442.00 -8.14 406.00 442.00 -8.14 1349.00 709.00 90.27
PBDT 5554.00 6031.00 -7.91 5554.00 6031.00 -7.91 16426.00 21396.00 -23.23
Depreciation 1231.00 1167.00 5.48 1231.00 1167.00 5.48 4787.00 4511.00 6.12
PBT 4323.00 4864.00 -11.12 4323.00 4864.00 -11.12 11639.00 16885.00 -31.07
TAX 1008.00 865.00 16.53 1008.00 865.00 16.53 3060.00 2123.00 44.14
Deferred Tax -6.00 15.00 -140.00 -6.00 15.00 -140.00 458.00 -910.00 -150.33
PAT 3315.00 3999.00 -17.10 3315.00 3999.00 -17.10 8579.00 14762.00 -41.88
Equity 1024.00 1024.00 0.00 1024.00 1024.00 0.00 1024.00 1024.00 0.00
PBIDTM(%) 30.09 30.48 -1.30 30.09 30.48 -1.30 26.27 30.82 -14.77

Zydus Lifesciences Share Price

930.95 -16.15 (-1.71%)
24-Apr-2026 09:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1638.00
Dr. Reddys Lab 1318.20
Cipla 1285.60
Zydus Lifesciences 930.95
Lupin 2316.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×